☰

Archibald J. Mixson - Publications

Affiliations: 
Chemical Engineering University of Maryland, College Park, College Park, MD 
Area:
Biomedical Engineering, Chemical Engineering, Materials Science Engineering, Polymer Chemistry, Oncology
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Mixson AJ, Leng Q, Chou ST, Woodle MC. Targeting Cancer with Peptide RNAi Nanoplexes. Methods in Molecular Biology (Clifton, N.J.). 1974: 161-180. PMID 31099002 DOI: 10.1007/978-1-4939-9220-1_12  0.588
2019 Zhao N, Leng Q, Woodle MC, Mixson AJ. Enhanced tumor uptake and activity of nanoplex-loaded doxorubicin. Biochemical and Biophysical Research Communications. PMID 30954222 DOI: 10.1016/j.bbrc.2019.03.190  0.326
2019 Leng Q, Woodle MC, Mixson AJ. NRP1 transport of cancer therapeutics mediated by tumor-penetrating peptides. Drugs of the Future. 42: 95-104. PMID 28603338 DOI: 10.1358/dof.2017.042.02.2564106  0.347
2017 Leng Q, Woodle MC, Mixson AJ. Targeted Delivery of siRNA Therapeutics to Malignant Tumors. Journal of Drug Delivery. 2017: 6971297. PMID 29218233 DOI: 10.1155/2017/6971297  0.337
2016 Leng Q, Mixson AJ. The neuropilin-1 receptor mediates enhanced tumor delivery of H2K polyplexes Journal of Gene Medicine. 18: 134-144. DOI: 10.1002/jgm.2886  0.425
2014 Chou ST, Mixson AJ. siRNA nanoparticles: the future of RNAi therapeutics for oncology? Nanomedicine (London, England). 9: 2251-4. PMID 25413851 DOI: 10.2217/Nnm.14.157  0.517
2014 Leng Q, Chou ST, Scaria PV, Woodle MC, Mixson AJ. Increased tumor distribution and expression of histidine-rich plasmid polyplexes. The Journal of Gene Medicine. 16: 317-28. PMID 25303767 DOI: 10.1002/Jgm.2807  0.542
2014 Lee A, Karcz A, Akman R, Zheng T, Kwon S, Chou ST, Sucayan S, Tricoli LJ, Hustedt JM, Leng Q, Kahn JD, Mixson AJ, Seog J. Direct observation of dynamic mechanical regulation of DNA condensation by environmental stimuli. Angewandte Chemie (International Ed. in English). 53: 10631-5. PMID 25146232 DOI: 10.1002/Anie.201403499  0.491
2014 Scaria PV, Liu Y, Leng Q, Chou ST, Mixson AJ, Woodle MC. Enhancement of antifungal activity by integrin-targeting of branched histidine rich peptides. Journal of Drug Targeting. 22: 536-42. PMID 24731059 DOI: 10.3109/1061186X.2014.905948  0.572
2014 Chou ST, Hom K, Zhang D, Leng Q, Tricoli LJ, Hustedt JM, Lee A, Shapiro MJ, Seog J, Kahn JD, Mixson AJ. Enhanced silencing and stabilization of siRNA polyplexes by histidine-mediated hydrogen bonds. Biomaterials. 35: 846-55. PMID 24161165 DOI: 10.1016/J.Biomaterials.2013.10.019  0.536
2013 Chou ST, Leng Q, Scaria P, Kahn JD, Tricoli LJ, Woodle M, Mixson AJ. Surface-modified HK:siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition. Biomacromolecules. 14: 752-60. PMID 23360232 DOI: 10.1021/Bm3018356  0.548
2012 Chou ST, Leng Q, Mixson AJ. Zinc Finger Nucleases: Tailor-made for Gene Therapy. Drugs of the Future. 37: 183-196. PMID 24155503 DOI: 10.1358/Dof.2012.037.03.1779022  0.533
2012 Leng Q, Chou ST, Scaria PV, Woodle MC, Mixson AJ. Buffering capacity and size of siRNA polyplexes influence cytokine levels. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 2282-90. PMID 23032972 DOI: 10.1038/Mt.2012.206  0.559
2011 Chou ST, Leng Q, Scaria P, Woodle M, Mixson AJ. Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo. Cancer Gene Therapy. 18: 707-16. PMID 21818135 DOI: 10.1038/cgt.2011.40  0.579
2011 Matejuk A, Leng Q, Chou ST, Mixson AJ. Vaccines targeting the neovasculature of tumors. Vascular Cell. 3: 7. PMID 21385454 DOI: 10.1186/2045-824X-3-7  0.54
2010 Matejuk A, Leng Q, Begum MD, Woodle MC, Scaria P, Chou ST, Mixson AJ. Peptide-based Antifungal Therapies against Emerging Infections. Drugs of the Future. 35: 197. PMID 20495663 DOI: 10.1358/Dof.2010.035.03.1452077  0.569
2009 Leng O, Woodle MC, Lu PY, Mixson AJ. Advances in systemic siRNA delivery Drugs of the Future. 34: 721-737. DOI: 10.1358/dof.2009.034.09.1413267  0.332
2008 Leng Q, Scaria P, Lu P, Woodle MC, Mixson AJ. Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts Cancer Gene Therapy. 15: 485-495. PMID 18483501 DOI: 10.1038/Cgt.2008.29  0.411
2007 Leng Q, Goldgeier L, Zhu J, Cambell P, Ambulos N, Mixson AJ. Histidine-lysine peptides as carriers of nucleic acids Drug News and Perspectives. 20: 77-86. DOI: 10.1358/dnp.2007.20.2.1083026  0.367
2006 Leng Q, Scaria P, Ioffe OB, Woodle M, Mixson AJ. A branched histidine/lysine peptide, H2K4b, in complex with plasmids encoding antitumor proteins inhibits tumor xenografts Journal of Gene Medicine. 8: 1407-1415. PMID 17133339 DOI: 10.1002/jgm.982  0.336
2006 Zhu J, Luther PW, Leng Q, Mixson AJ. Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: Role of endocytosis and treatment implications Antimicrobial Agents and Chemotherapy. 50: 2797-2805. PMID 16870774 DOI: 10.1128/AAC.00411-06  0.355
2005 Schiffelers RM, Mixson AJ, Ansari AM, Fens MH, Tang Q, Zhou Q, Xu J, Molema G, Lu PY, Scaria PV, Storm G, Woodle MC. Transporting silence: design of carriers for siRNA to angiogenic endothelium. Journal of Controlled Release : Official Journal of the Controlled Release Society. 109: 5-14. PMID 15979191 DOI: 10.1016/J.Jconrel.2005.05.018  0.419
2005 Leng Q, Mixson AJ. Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo Cancer Gene Therapy. 12: 682-690. PMID 15803144 DOI: 10.1038/Sj.Cgt.7700831  0.393
2005 Leng Q, Mixson AJ. Modified branched peptides with a histidine-rich tail enhance in vitro gene transfection Nucleic Acids Research. 33: 1-9. DOI: 10.1093/nar/gni040  0.369
2000 Zhang L, Chen QR, Mixson AJ. Antiangiogenic gene therapy in cancer Current Genomics. 1: 117-133.  0.322
Show low-probability matches.